CLOV — CLOVER HEALTH INVESTMENTS, CORP. /DE
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2020-06-12.
Performance
Technicals
Others in Healthcare
Measured signals that fired on CLOV
| date | signal | measured base rate |
|---|---|---|
| 2026-08-06 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-06-22 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-06-03 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-05-28 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-04-23 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-04-07 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-17 | THORNTON JOSEPH CLAY Interim CFO | Open-market sale 10b5-1 plan | 17.8K | 4.39 | 78.0K |
| 2026-08-12 | Soares Karen Chief Legal Officer | Grant or award | 108.7K | 0.00 | 0 |
| 2026-08-12 | THORNTON JOSEPH CLAY Interim CFO | Grant or award | 54.3K | 0.00 | 0 |
| 2026-08-10 | Toy Andrew Chief Executive Officer | Open-market sale 10b5-1 plan | 87.8K | 4.65 | 408.3K |
| 2026-07-20 | Soares Karen Chief Legal Officer | Open-market sale 10b5-1 plan | 51.7K | 4.51 | 233.2K |
| 2026-07-17 | Reynoso Jamie L. CEO, Medicare Advantage | Open-market sale 10b5-1 plan | 4.8K | 4.53 | 21.9K |
| 2026-07-15 | Toy Andrew Chief Executive Officer | Open-market sale 10b5-1 plan | 62.7K | 4.67 | 292.9K |
| 2026-07-15 | Wai Conrad CEO, Counterpart Health | Open-market sale 10b5-1 plan | 24.2K | 4.67 | 113.1K |
| 2026-07-15 | Reynoso Jamie L. CEO, Medicare Advantage | Open-market sale 10b5-1 plan | 13.1K | 4.67 | 61.3K |
| 2026-07-15 | Soares Karen Chief Legal Officer | Open-market sale 10b5-1 plan | 10.5K | 4.67 | 49.1K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 56.0M | 31.8M |
| VANGUARD CAPITAL MANAGEMENT LLC | 29.9M | 17.0M |
| GEODE CAPITAL MANAGEMENT, LLC | 17.7M | 10.1M |
| STATE STREET CORP | 16.8M | 9.6M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 9.3M | 5.3M |
| PNC FINANCIAL SERVICES GROUP, INC. | 6.6M | 3.8M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.5M | 3.7M |
| DIMENSIONAL FUND ADVISORS LP | 6.0M | 3.4M |
| RENAISSANCE TECHNOLOGIES LLC | 6.0M | 3.4M |
| NORTHERN TRUST CORP | 5.8M | 3.3M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 4 | 2026-08-17 | 2026-08-17 | on EDGAR ↗ |
| 144 | 2026-08-17 | — | on EDGAR ↗ |
| 144 | 2026-08-14 | — | on EDGAR ↗ |
| 4 | 2026-08-13 | 2026-08-12 | on EDGAR ↗ |
| 4 | 2026-08-13 | 2026-08-12 | on EDGAR ↗ |
| 4 | 2026-08-10 | 2026-08-10 | on EDGAR ↗ |
| 144 | 2026-08-10 | — | on EDGAR ↗ |
| 144 | 2026-08-07 | — | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Clover Health Investments, Corp. /de (CLOV) filed form 8-K · 2026-08-20 · SEC EDGAR
- CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) filed form 4 · 2026-08-17 · SEC EDGAR
- CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) filed form 144 · 2026-08-17 · SEC EDGAR
Ask the AI about CLOV
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →